Home Cart 0 Sign in  
X

[ CAS No. 38533-61-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 38533-61-8
Chemical Structure| 38533-61-8
Chemical Structure| 38533-61-8
Structure of 38533-61-8 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 38533-61-8 ]

Related Doc. of [ 38533-61-8 ]

Alternatived Products of [ 38533-61-8 ]

Product Details of [ 38533-61-8 ]

CAS No. :38533-61-8 MDL No. :MFCD00130268
Formula : C6H5ClN2O3 Boiling Point : -
Linear Structure Formula :- InChI Key :DVRGUTNVDGIKTP-UHFFFAOYSA-N
M.W : 188.57 Pubchem ID :2795029
Synonyms :

Calculated chemistry of [ 38533-61-8 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.17
Num. rotatable bonds : 2
Num. H-bond acceptors : 4.0
Num. H-bond donors : 0.0
Molar Refractivity : 44.56
TPSA : 67.94 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.07 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.47
Log Po/w (XLOGP3) : 1.95
Log Po/w (WLOGP) : 1.65
Log Po/w (MLOGP) : 0.06
Log Po/w (SILICOS-IT) : -0.13
Consensus Log Po/w : 1.0

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.48
Solubility : 0.631 mg/ml ; 0.00334 mol/l
Class : Soluble
Log S (Ali) : -3.0
Solubility : 0.188 mg/ml ; 0.000997 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.15
Solubility : 1.33 mg/ml ; 0.00705 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 3.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.03

Safety of [ 38533-61-8 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 38533-61-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 38533-61-8 ]
  • Downstream synthetic route of [ 38533-61-8 ]

[ 38533-61-8 ] Synthesis Path-Upstream   1~13

  • 1
  • [ 38533-61-8 ]
  • [ 34392-85-3 ]
YieldReaction ConditionsOperation in experiment
72%
Stage #1: With water; tin(ll) chloride In ethyl acetate at 70℃; for 1 h;
Stage #2: With sodium carbonate In water; ethyl acetate at 20℃;
Tin(ll)chloride dihydrate (6 g, 26.52 mmol) was added to a solution of 2-chloro-6-methoxy- 3-nitropyridine (1 g, 5.30 mmol) in ethyl acetate (15 ml.) and the resultant suspension heated at 70 °C with stirring for 1 h. The reaction mixture was cooled to ambient temperature, the pH adjusted to pH 9-10 by addition of saturated sodium carbonate (aq.) and extracted with ethyl acetate (3 x 5OmL). The combined extracts were dried (MgSO4) and concentrated in vacuo to give the crude product. Purification by chromatography on silica gel with EtOAc:heptane (3:7, v/v) as eluent afforded the product as a pale yellow oil (600 mg, 72 percent). Data for S-amino-σ-chloro-e-methoxypyridine: MS (ESI) m/z: 159 ([M+H]+).
69% With hydrogen In ethanol; ethyl acetate at 15 - 25℃; A solution of 2-chloro-6-methoxy-3-nitropyridine (1.0 g, 5.3 mmol) in EtOH (50 ml)/EtOAc (50 ml) is hydrogenated at RT and 40 psi, in the presence of 10percent Pd-C (0.394 g, 0.37 mmol). The suspension is filtered through cellulose and washed with EtOH. The solution is concentrated under vacuum to give a brown oil 0.58 g (69percent yield) that is used without further purification in the next step. MS (ESI+) for C6H7ClN2O m/z 159.0 (M+H)+. Example 310 (from 2-chloro-6-methoxypyridin-3-amine and 2-isocyanato-5-(trifluoromethyl)-1,3,4-thiadiazole) is prepared by following Method C, making non-critical modifications. The solid is triturated with CH2Cl2 to give a white solid 0.104 g (47percent yield). HRMS (ESI) calcd for C10H7N5O2SClF3+H 354.0039, found 354.0046.
Reference: [1] Journal of Organic Chemistry, 2011, vol. 76, # 23, p. 9841 - 9844
[2] Organic Letters, 2016, vol. 18, # 11, p. 2774 - 2776
[3] Patent: WO2007/39563, 2007, A1, . Location in patent: Page/Page column 26
[4] Patent: US2007/112019, 2007, A1, . Location in patent: Page/Page column 13/2
[5] Patent: US2003/236287, 2003, A1, . Location in patent: Page 40
[6] Patent: WO2005/7648, 2005, A2, . Location in patent: Page 87
[7] Patent: WO2007/113548, 2007, A1, . Location in patent: Page/Page column 144
  • 2
  • [ 38533-61-8 ]
  • [ 73896-36-3 ]
YieldReaction ConditionsOperation in experiment
74% With ammonia In methanol at 65℃; for 18 h; Example 26; 6- [({2- [6-(methyloxy)-3-oxopyrido [2,3-b] pyrazin-4(3H)-yl] -5,6,7,8- tetrahydro-6-quinazolinyl}amino)methyl]-2H-pyrido[3,2-b][l,4]oxazin-3(4H)-one hydrochloride; (a) 6-(Methyloxy)-3 -nitro-2-pyridinamine; A solution/suspension of 2-chloro-6-(methyloxy)-3-nitropyridine (65.7 g, 348 mmol) in 2M ammonia in methanol (500 ml, 1000 mmol) and aqueous ammonia (500 ml, 348 mmol) was stirred at 65°C for 18h. The reaction was cooled down and the solid filtered off and washed with water (2x100ml). The solid was dried in the vacuum oven at 4O0C overnight to afford the product as a bright yellow solid (52.14g, 84percent purity by NMR, 74percent). MS (ES+) m/z 170 (MH+).
74% With ammonia In methanol at 65℃; for 18 h; Example 13A; (lR)-l-({4-[([l,3]Oxathiolo[5,4-c]pyridin-6-ylmethyl)amino]-l- piperidinyl}methyl)-l,2-dihydro-3H,8H-2a,5,8a-triazaacenaphthylene-3,8-dione hydrochloride; <n="57"/>(a) 6-(Methyloxy)-3 -nitro-2-pyridinamine; A solution/suspension of 2-chloro-6-(methyloxy)-3-nitropyridine (65.7 g, 348 mmol) in 2M ammonia in methanol (500 ml, 1000 mmol) and aqueous ammonia (500 ml, 348 mmol) was stirred at 65 0C for 18h. The reaction was cooled down and the solid filtered off and washed with water (2x100ml). The solid was dried in the vacuum oven at 4O0C overnight to afford the product as a bright yellow solid (52.14g, 84percent purity by NMR, 74percent).MS (ES+) m/z 170 (MH+).
74% With ammonia In DMF (N,N-dimethyl-formamide); water at 70℃; for 4.25 h; Preparation Example 1; '6-Methoxy-3-nitro-2-pyridineamine [Formula 50]; A solution of 2-chloro-6-methoxy-3- nitropyridine (25.3 g, 0.134 mol) and a concentrated aqueous ammonia solution (70 ml) in N,N- dimethylformamide (200 ml) was stirred at 70°C for 4 hours and 15 minutes. The reaction mixture was cooled to room temperature and then diluted with water. The resulted precipitate was collected by filtration to yield the title compound (16.8 g, 99.2 mmol, 74.0percent) as a yellow solid. 1H NMR(400 MHz, DMSO-d6) No.ppm; 3.90(3H, s), 6.16(lH, d, J=9Hz), 8.16 (2H, br s), 8.26(lH, d, J=9Hz).
86% With pyridine; ammonium carbonate In dichloromethane A.
6-Methoxy-3-nitro-pyridin-2-ylamine.
Scheme 8.
To a glass pressure vessel was added 2-chloro-6-methoxy-3-nitro-pyridine (10.0 g, 53 mmol), ammonium carbonate (12.4 g, 159 mmol) and pyridine (100 mL).
The mixture was heated at 40° C. for 24 h.
The reaction mixture was concentrated in vacuo, and the residue was taken up in CH2Cl2 and chromatographed (silica gel; CH2Cl2) yielding 7.6 g (86percent) of 6-methoxy-3-nitro-pyridin-2-ylamine.
HPLC: Rt=7.89. 1H NMR (400 MHz, DMSO-d6): 8.26 (d, J=9.1 Hz, 1H), 8.17 (br s, 2H), 6.15 (d, J=9.1 Hz, 1H), 3.89 (s, 3H).

Reference: [1] Patent: WO2008/128961, 2008, A1, . Location in patent: Page/Page column 24; 85
[2] Patent: WO2008/128942, 2008, A1, . Location in patent: Page/Page column 55-56
[3] Patent: WO2005/103049, 2005, A1, . Location in patent: Page/Page column 102-103
[4] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 7, p. 1924 - 1928
[5] Patent: US2003/176438, 2003, A1,
[6] Patent: US2008/125358, 2008, A1, . Location in patent: Page/Page column 18
[7] Patent: WO2009/87153, 2009, A1, . Location in patent: Page/Page column 47-48
[8] Patent: US2009/306089, 2009, A1, . Location in patent: Page/Page column 21
  • 3
  • [ 38533-61-8 ]
  • [ 27048-04-0 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 7, p. 1924 - 1928
  • 4
  • [ 16013-85-7 ]
  • [ 40851-91-0 ]
  • [ 38533-61-8 ]
Reference: [1] Patent: US6376538, 2002, B1,
[2] Patent: US6306840, 2001, B1,
  • 5
  • [ 67-56-1 ]
  • [ 16013-85-7 ]
  • [ 40851-91-0 ]
  • [ 38533-61-8 ]
  • [ 18677-41-3 ]
Reference: [1] Tetrahedron Letters, 2011, vol. 52, # 32, p. 4172 - 4176
  • 6
  • [ 67-56-1 ]
  • [ 16013-85-7 ]
  • [ 38533-61-8 ]
YieldReaction ConditionsOperation in experiment
56% With sodium hydride In tetrahydrofuran; mineral oil at 0 - 20℃; for 2.5 h; To a 500 mL four-neck flask were treated with THF (120 mL), MeOH (3.66 g, 115 mmol, 0.95 eq) and 2,6-dichloro-3-nitropyridine (23 g, 120 mmol, 1 eq). After cooling down to 0 oC, 60percent NaH (6.8 g, 170 mmol, 1.7 eq) was added carefully. The mixture was stirred at this temperature for 30 minutes, then at RT for 2 hours. After completion, the mixture was quenched with water (100 mL), extracted with EA (3×150 mL), the combined organic layers were dried, concentrated and purified by silica column to give 2-chloro-6-methoxy-3-nitropyridine (12 g, 56percent). 1HNMR (300 MHz, CDCl3): G 8.37- 8.24 (m, 1 H), 7.07- 7.05 (m, 1 H), 4.15 (s, 3 H).
Reference: [1] Patent: WO2017/120429, 2017, A1, . Location in patent: Page/Page column 348
  • 7
  • [ 16013-85-7 ]
  • [ 40851-91-0 ]
  • [ 38533-61-8 ]
Reference: [1] Patent: US6376538, 2002, B1,
[2] Patent: US6306840, 2001, B1,
  • 8
  • [ 17228-64-7 ]
  • [ 38533-61-8 ]
Reference: [1] Patent: US4529800, 1985, A,
  • 9
  • [ 67-56-1 ]
  • [ 16013-85-7 ]
  • [ 40851-91-0 ]
  • [ 38533-61-8 ]
  • [ 18677-41-3 ]
Reference: [1] Tetrahedron Letters, 2011, vol. 52, # 32, p. 4172 - 4176
  • 10
  • [ 16013-85-7 ]
  • [ 124-41-4 ]
  • [ 38533-61-8 ]
Reference: [1] Journal of Agricultural and Food Chemistry, 2015, vol. 63, # 34, p. 7469 - 7475
  • 11
  • [ 67-56-1 ]
  • [ 16013-85-7 ]
  • [ 40851-91-0 ]
  • [ 38533-61-8 ]
  • [ 18677-41-3 ]
Reference: [1] Tetrahedron Letters, 2011, vol. 52, # 32, p. 4172 - 4176
  • 12
  • [ 38533-61-8 ]
  • [ 83732-68-7 ]
Reference: [1] Patent: WO2005/7648, 2005, A2,
  • 13
  • [ 38533-61-8 ]
  • [ 198268-98-3 ]
YieldReaction ConditionsOperation in experiment
76%
Stage #1: at 90℃; for 3 h;
Stage #2: With sodium hydroxide In water
A suspension of 2-chloro-6-methoxy-3-nitropyridine (20.85 g, 110.57 mmol) in concentrated hydrochloric acid (37percent) (171 mL, 5528.49 mmol) was stirred at 90 0C for 3 hours and allowed to cool to ambient temperature. The suspension was adjusted to pH 5 with 2M NaOH and the aqueous mixture was then continually extracted with EtOAc (250 mL). The organics were concentrated to afford a yellow solid which was filtered off and washed with Et2ψ (200 mL). The solid was stirred in EtOAc (200 mL) and the green insoluble solid filtered off. Both filtrates were combined and dried (MgSO4) before <n="144"/>concentrating to yield as 6-chloro-5-nitropyridin-2-ol a yellow solid (14.7 g, 84.22 mmol, 76 percent).1R NMR (400 MHz, DMSOd6) δ 6.52 (IH, d), 8.26 (IH, d), no OH peak observed, m/z 173 (M-H)"
60% at 90℃; for 16 h; A mixture of 2-chloro-6-methoxy-3-nitropyridine (5 g, 10.61 mmol) in HCl solution (12 M, 60 mL) was stirred at 90° C. for 16 h. Then the reaction mixture was neutralized with NaOH carefully and extracted with EtOAc (100 mL*2). The organic phases were combined, washed with brine and dried over Na2SO4. The solvent was removed under reduced pressure to yield 6-chloro-5-nitropyridin-2-ol (2.8 g, 60percent) as red solid which was used in the following reaction without further purification. MS: m/z=197.1 [M+Na]+.
Reference: [1] Patent: WO2009/24821, 2009, A2, . Location in patent: Page/Page column 142-143
[2] Patent: US2016/75711, 2016, A1, . Location in patent: Paragraph 0792-0793
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 38533-61-8 ]

Chlorides

Chemical Structure| 34392-85-3

[ 34392-85-3 ]

3-Amino-2-chloro-6-methoxypyridine

Similarity: 0.81

Chemical Structure| 5470-18-8

[ 5470-18-8 ]

2-Chloro-3-nitropyridine

Similarity: 0.78

Chemical Structure| 1003711-55-4

[ 1003711-55-4 ]

2-Chloro-5-methoxy-3-nitropyridine

Similarity: 0.76

Chemical Structure| 23056-39-5

[ 23056-39-5 ]

2-Chloro-4-methyl-3-nitropyridine

Similarity: 0.74

Chemical Structure| 23056-40-8

[ 23056-40-8 ]

2-Chloro-5-methyl-3-nitropyridine

Similarity: 0.73

Ethers

Chemical Structure| 34392-85-3

[ 34392-85-3 ]

3-Amino-2-chloro-6-methoxypyridine

Similarity: 0.81

Chemical Structure| 1003711-55-4

[ 1003711-55-4 ]

2-Chloro-5-methoxy-3-nitropyridine

Similarity: 0.76

Chemical Structure| 6980-09-2

[ 6980-09-2 ]

2-Chloro-4-methoxy-3-nitropyridine

Similarity: 0.73

Chemical Structure| 6635-90-1

[ 6635-90-1 ]

2-Methoxy-4-methyl-5-nitropyridine

Similarity: 0.73

Chemical Structure| 52854-14-5

[ 52854-14-5 ]

4-Chloro-6-methoxy-5-nitropyrimidine

Similarity: 0.70

Nitroes

Chemical Structure| 5470-18-8

[ 5470-18-8 ]

2-Chloro-3-nitropyridine

Similarity: 0.78

Chemical Structure| 1003711-55-4

[ 1003711-55-4 ]

2-Chloro-5-methoxy-3-nitropyridine

Similarity: 0.76

Chemical Structure| 23056-39-5

[ 23056-39-5 ]

2-Chloro-4-methyl-3-nitropyridine

Similarity: 0.74

Chemical Structure| 23056-40-8

[ 23056-40-8 ]

2-Chloro-5-methyl-3-nitropyridine

Similarity: 0.73

Chemical Structure| 6980-09-2

[ 6980-09-2 ]

2-Chloro-4-methoxy-3-nitropyridine

Similarity: 0.73

Related Parent Nucleus of
[ 38533-61-8 ]

Pyridines

Chemical Structure| 34392-85-3

[ 34392-85-3 ]

3-Amino-2-chloro-6-methoxypyridine

Similarity: 0.81

Chemical Structure| 5470-18-8

[ 5470-18-8 ]

2-Chloro-3-nitropyridine

Similarity: 0.78

Chemical Structure| 1003711-55-4

[ 1003711-55-4 ]

2-Chloro-5-methoxy-3-nitropyridine

Similarity: 0.76

Chemical Structure| 23056-39-5

[ 23056-39-5 ]

2-Chloro-4-methyl-3-nitropyridine

Similarity: 0.74

Chemical Structure| 23056-40-8

[ 23056-40-8 ]

2-Chloro-5-methyl-3-nitropyridine

Similarity: 0.73